These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26463985)

  • 1. Inodilators in the Management of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery.
    Ferrer-Barba A; Gonzalez-Rivera I; Bautista-Hernandez V
    Curr Vasc Pharmacol; 2016; 14(1):48-57. PubMed ID: 26463985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome.
    Uhlig K; Efremov L; Tongers J; Frantz S; Mikolajczyk R; Sedding D; Schumann J
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD009669. PubMed ID: 33152122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levosimendan in cardiac surgery: a unique drug for the treatment of perioperative left ventricular dysfunction or just another inodilator searching for a clinical application?
    Pagel PS
    Anesth Analg; 2007 Apr; 104(4):759-61. PubMed ID: 17377077
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.
    Burkhardt BE; Rücker G; Stiller B
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD009515. PubMed ID: 25806562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levosimendan for preventing low output syndrome in pediatric patients with correction of tetralogy of Fallot].
    Gutiérrez-Riveroll KI; Mejía Picazo HJ; Dosta-Herrera JJ
    Rev Med Inst Mex Seguro Soc; 2022 May; 60(3):304-314. PubMed ID: 35763357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levosimendan in regional myocardial ischemia.
    Pieske B
    Cardiovasc Drugs Ther; 2002 Sep; 16(5):379-81. PubMed ID: 12656119
    [No Abstract]   [Full Text] [Related]  

  • 8. Levosimendan for Perioperative Cardioprotection: Myth or Reality?
    Santillo E; Migale M; Massini C; Incalzi RA
    Curr Cardiol Rev; 2018; 14(3):142-152. PubMed ID: 29564979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery.
    Labriola C; Siro-Brigiani M; Carrata F; Santangelo E; Amantea B
    Int J Clin Pharmacol Ther; 2004 Apr; 42(4):204-11. PubMed ID: 15124978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of levosimendan treatment of myocardial stunning and low-output syndrome after cardiac surgery].
    García-González MJ; Domínguez-Rodríguez A
    Rev Esp Cardiol; 2006 Aug; 59(8):851-2. PubMed ID: 16938238
    [No Abstract]   [Full Text] [Related]  

  • 12. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
    Unverzagt S; Wachsmuth L; Hirsch K; Thiele H; Buerke M; Haerting J; Werdan K; Prondzinsky R
    Cochrane Database Syst Rev; 2014 Jan; (1):CD009669. PubMed ID: 24385385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study.
    Lechner E; Hofer A; Leitner-Peneder G; Freynschlag R; Mair R; Weinzettel R; Rehak P; Gombotz H
    Pediatr Crit Care Med; 2012 Sep; 13(5):542-8. PubMed ID: 22622649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-dependent effects of milrinone and levosimendan on ventricular function and haemodynamics in newborn and mature pigs.
    Hyldebrandt JA; Larsen SH; Schmidt MR; Hjortdal VE; Ravn HB
    Cardiol Young; 2011 Oct; 21(5):518-27. PubMed ID: 21733205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Levosimendan and low cardiac output syndrome. Does mortality really decrease? ].
    Alvarez J
    Rev Esp Cardiol; 2008 May; 61(5):454-7. PubMed ID: 18462647
    [No Abstract]   [Full Text] [Related]  

  • 16. Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output.
    Elahi MM; Lam J; Asopa S; Matata BM
    J Cardiothorac Vasc Anesth; 2011 Dec; 25(6):1154-62. PubMed ID: 21376634
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of Levosimendan in Postoperative Setting After Surgical Repair of Congenital Heart Disease in Children.
    Amiet V; Perez MH; Longchamp D; Boulos Ksontini T; Natterer J; Plaza Wuthrich S; Cotting J; Di Bernardo S
    Pediatr Cardiol; 2018 Jan; 39(1):19-25. PubMed ID: 28884218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milrinone is preferred to levosimendan for mesenteric perfusion in hypoxia-reoxygenated newborn piglets treated with dopamine.
    Manouchehri N; Bigam DL; Churchill T; Joynt C; Vento M; Cheung PY
    Pediatr Res; 2012 Mar; 71(3):241-6. PubMed ID: 22337258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
    Hummel J; Rücker G; Stiller B
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011312. PubMed ID: 28262914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Levosimendan].
    Michels G; Herzig S; Hoppe UC
    Dtsch Med Wochenschr; 2005 Oct; 130(43):2444-6. PubMed ID: 16240243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.